# Johnson & Johnson Development Corporation (JJDC): portfolio, investments and team

> Johnson & Johnson Development Corporation (JJDC) is a vc firm based in United States. 117 investments on record, latest Nov 2014.

Source: https://millionrounds.com/fund/johnson-and-johnson-development-corporation (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Johnson & Johnson Development Corporation (JJDC)

Last cheque observed Nov 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

Quiet VC firm

Buyout Growth Seed Biotech Consumer Consumer Products

Follow Johnson & Johnson Development Corporation (JJDC) and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fjohnson-and-johnson-development-corporation)

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 117 on record

Since the last cheque **4368** days **00** hrs **00** min **00** sec

Median round **$25M** Rounds led **0 of 117** Sole investor **5 rounds** Exits **12 from the portfolio** Mostly in **United States, 67%**

Pitch Johnson & Johnson Development Corporation (JJDC)

## Johnson & Johnson Development Corporation (JJDC) highlights

- 01 117 rounds on record
- 02 Mostly Series B and Series C: 55% of its rounds
- 03 Sole investor in 5 rounds, median $9.0M
- 04 12 exits from the portfolio

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Buyout Growth Seed Series A
- **Sectors:** Biotech Consumer Consumer Products
- **Based in:** United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **117 appearances**

- **2014** 11 rounds
- **Nov** **[La Lumiere](https://millionrounds.com/company/la-lumiere)** Series B · US **$20M** With 1 other
- **Sept** **[Inivata](https://millionrounds.com/company/inivata)** Series A · GB **$6.5M** With 2 others
- **Sept** **[Biocartis](https://millionrounds.com/company/biocartis)** Series F · CH **$85M** With 2 others
- **Jun** **[Navitor Pharmaceuticals](https://millionrounds.com/company/navitor-pharmaceuticals)** Series A · US **$24M** With 3 others
- **Jun** **[Aduro BioTech](https://millionrounds.com/company/aduro-biotech)** Series C · US **$55M** With 1 other
- **May** **[Rodin Therapeutics](https://millionrounds.com/company/rodin-therapeutics)** Series A · US **$13M** With 1 other
- **May** **[Inspire Medical Systems](https://millionrounds.com/company/inspire-medical-systems)** Series E · US **$40M** With 8 others
- **Apr** **[Atlas Genetics](https://millionrounds.com/company/atlas-genetics)** Series B · GB **$28M** With 5 others
- **Feb** **[Thesan Pharmaceuticals](https://millionrounds.com/company/thesan-pharmaceuticals)** Series B **$49M** With 6 others
- **Jan** **[PowerVision](https://millionrounds.com/company/powervision)** Series D · US **$20M** With 6 others
- **Jan** **[TopiVert](https://millionrounds.com/company/topivert)** Venture · GB **$6.8M** With 3 others
- **2013** 14 rounds
- **Nov** **[Pulmocide](https://millionrounds.com/company/pulmocide)** Series A · GB · finsmes.com **$28M** With 4 others
- **Nov** **[Biocartis](https://millionrounds.com/company/biocartis)** Series E · CH · finsmes.com **$39M** With 5 others
- **Oct** **[Merus](https://millionrounds.com/company/merus)** Series B · NL · finsmes.com **$40M** With 4 others
- **Jul** **[ReVision Optics](https://millionrounds.com/company/revision-optics)** Series E · US · finsmes.com **$55M** With 5 others
- **Jul** **[CVRx](https://millionrounds.com/company/cvrx)** Series F · US · finsmes.com **$30M** With 4 others
- **Jul** **[ViaCyte](https://millionrounds.com/company/viacyte)** Series C · US · pehub.com **$11M** With 1 other
- **Jul** **[NeuroPace](https://millionrounds.com/company/neuropace)** Venture · US · bizjournals.com **$18M** With 4 others
- **Jun** **[Rodin Therapeutics](https://millionrounds.com/company/rodin-therapeutics)** Seed · US · pevc.dowjones.com **Undisclosed** With 1 other
- **Jun** **[Protagonist Therapeutics](https://millionrounds.com/company/protagonist-therapeutics)** Series B · AU · protagonist-inc.com **$14M** With 2 others
- **Apr** **[ReVision Optics](https://millionrounds.com/company/revision-optics)** Series E · US · sec.gov **$15M** With 4 others
- **Apr** **[Aquinox Pharmaceuticals](https://millionrounds.com/company/aquinox-pharmaceuticals)** Series C · CA · finance.yahoo.com **$18M** With 4 others
- **Apr** **[Catalyst Biosciences](https://millionrounds.com/company/catalyst-biosciences)** Venture · US **$5.1M** With 5 others
- **Mar** **[Nevro](https://millionrounds.com/company/nevro)** Series C · US · finsmes.com **$48M** With 8 others
- **Feb** **[OptiScan Biomedical](https://millionrounds.com/company/optiscan-biomedical)** Growth · US · venturedeal.com **$31M** With 3 others
- **2012** 11 rounds
- **Dec** **[Biocartis](https://millionrounds.com/company/biocartis)** Series D · CH **$45M** With 4 others
- **Oct** **[Genocea Biosciences](https://millionrounds.com/company/genocea-biosciences)** Series C · US · masshightech.com **$30M** With 9 others
- **Sept** **[Catalyst Biosciences](https://millionrounds.com/company/catalyst-biosciences)** Venture · US · sec.gov **$13M** With 4 others
- **Jun** **[Astute Medical](https://millionrounds.com/company/astute-medical)** Series C · US · finsmes.com **$40M** With 5 others
- **Jun** **[PhaseBio Pharmaceuticals](https://millionrounds.com/company/phasebio-pharmaceuticals)** Series B · US · pevc.dowjones.com **$23M** With 4 others
- **May** **[Mitralign](https://millionrounds.com/company/mitralign)** Series D · US · finsmes.com **$35M** With 5 others
- **Apr** **[Direct Flow Medical](https://millionrounds.com/company/direct-flow-medical)** Venture · US **$284K** With 8 others
- **Feb** **[Celladon](https://millionrounds.com/company/celladon)** Venture · US · finsmes.com **$43M** With 5 others
- **Jan** **[iScience Interventional](https://millionrounds.com/company/iscience-interventional)** Venture · US · researchviews.com **$2.8M** With 5 others
- **Jan** **[PowerVision](https://millionrounds.com/company/powervision)** Series C · US · finsmes.com **$13M** Sole investor
- **Jan** **[Pronota](https://millionrounds.com/company/pronota)** Series C · BE · pronota.com **$4.8M** With 6 others
- **2011** 8 rounds
- **Nov** **[Biocartis](https://millionrounds.com/company/biocartis)** Series C · CH · finsmes.com **$96M** With 2 others
- **Jul** **[Nevro](https://millionrounds.com/company/nevro)** Venture · US · finsmes.com **$58M** With 6 others
- **Jul** **[Atlas Genetics](https://millionrounds.com/company/atlas-genetics)** Series B · GB · atlasgenetics.com **$27M** With 4 others
- **Jun** **[Spinal Modulation](https://millionrounds.com/company/spinal-modulation)** Series D · US · businesswire.com **$30M** With 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **1** person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **12 in all**

**[Accumetrics](https://millionrounds.com/company/accumetrics)** Bought by [ITC](https://millionrounds.com/fund/itc) **Undisclosed** Aug 2013

**[Syntaxin](https://millionrounds.com/company/syntaxin)** Bought by [Ipsen](https://millionrounds.com/fund/ipsen) **$206M** Jul 2013

**[InfoMedics](https://millionrounds.com/company/infomedics)** Bought by Physicians Interactive **Undisclosed** Dec 2012

**[Acuity Pharmaceuticals](https://millionrounds.com/company/acuity-pharmaceuticals)** Bought by [OPKO Health](https://millionrounds.com/fund/opko-health) **Undisclosed** Jun 2011

**[Tengion](https://millionrounds.com/company/tengion)** Listed **Undisclosed** Apr 2010

**[InSound Medical](https://millionrounds.com/company/insound-medical)** Bought by Sonova Holding **Undisclosed** Jan 2010

**[Replidyne](https://millionrounds.com/company/replidyne)** Bought by [Cardiovascular Systems](https://millionrounds.com/fund/cardiovascular-systems) **Undisclosed** Feb 2009

**[Critical Therapeutics,Inc.](https://millionrounds.com/company/critical-therapeutics-inc)** Bought by Cornerstone Therapeutics **Undisclosed** May 2008

**[Vascular Architects](https://millionrounds.com/company/vascular-architects)** Bought by LeMaitre Vascular **Undisclosed** Sept 2007

**[BioRexis](https://millionrounds.com/company/biorexis)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Feb 2007

**[Cyrano Sciences](https://millionrounds.com/company/cyrano-sciences)** Bought by Smiths Detection **Undisclosed** Mar 2004

**[CardioMEMS](https://millionrounds.com/company/cardiomems)** Bought by [St. Jude Medical](https://millionrounds.com/fund/st-jude-medical) **Undisclosed** Nov 2003

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Buyout Growth Seed

Median round joined **$25M** the round, not its cheque Alone, median **$9.0M**

Led 0 of 117 rounds **0%**

- **Sole investor:** 5 rounds
- **Last cheque:** Nov 2014
- **Exits:** 12 from the portfolio

Rounds by stage said on their site

- Series B *30*
- Series C *29*
- Series A said *15*
- Venture *14*
- Series D *12*
- Series E *7*
- Buyout said *-*

Cheques by year Led Joined

2000 2014

Often in the room with

- [Domain Associates](https://millionrounds.com/fund/domain-associates) 11
- [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 9
- [Quaker Partners](https://millionrounds.com/fund/quaker-partners) 9
- [De Novo Ventures](https://millionrounds.com/fund/de-novo-ventures) 8
- [EQT life science](https://millionrounds.com/fund/lsp-bioventures) 8
- [Novartis Venture Fund](https://millionrounds.com/fund/novartis-venture-fund) 8

**Pitching Johnson & Johnson Development Corporation (JJDC)?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Johnson & Johnson Development Corporation (JJDC). A count of rooms they were both in, not a relationship either has claimed.

[**Domain Associates** VC firm **11** rounds together](https://millionrounds.com/fund/domain-associates)[**New Enterprise Associates** VC firm **9** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Quaker Partners** VC firm **9** rounds together](https://millionrounds.com/fund/quaker-partners)[**De Novo Ventures** Growth equity **8** rounds together](https://millionrounds.com/fund/de-novo-ventures)[**EQT life science** Private equity **8** rounds together](https://millionrounds.com/fund/lsp-bioventures)[**Novartis Venture Fund** Corporate VC **8** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**Polaris Partners** VC firm **8** rounds together](https://millionrounds.com/fund/polaris-partners)[**Essex Woodlands Healthcare Partners** VC firm **7** rounds together](https://millionrounds.com/fund/essex-woodlands-health-ventures)[**HealthCare Ventures** Growth equity **7** rounds together](https://millionrounds.com/fund/healthcare-ventures-llc)[**SR One** Corporate VC **7** rounds together](https://millionrounds.com/fund/sr-one)[**Canaan** VC firm **6** rounds together](https://millionrounds.com/fund/canaan-partners)[**Kleiner Perkins Caufield & Byers** VC firm **6** rounds together](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers)

## Quick answers about Johnson & Johnson Development Corporation (JJDC)

### What does Johnson & Johnson Development Corporation (JJDC) invest in?

Johnson & Johnson Development Corporation (JJDC) invests most often at Series B and Series C (55% of the rounds on record), in sectors such as Biotech, Consumer and Consumer Products.

### How active is Johnson & Johnson Development Corporation (JJDC)?

117 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2014.

### How big are Johnson & Johnson Development Corporation (JJDC)'s cheques?

The median round it joins is $25M.

### Does Johnson & Johnson Development Corporation (JJDC) lead rounds?

Rarely, if at all: none of its 117 investments on record names it as the lead.

### Where does Johnson & Johnson Development Corporation (JJDC) invest?

Most of the companies it backs are in the United States (67%), the United Kingdom (13%) and Switzerland (10%).

### Is Johnson & Johnson Development Corporation (JJDC) investing now?

No investments in the last 12 months; the latest was in Nov 2014.

### Who does Johnson & Johnson Development Corporation (JJDC) invest alongside?

Most often Domain Associates (11 rounds together), New Enterprise Associates (9 rounds together) and Quaker Partners (9 rounds together).

### What kind of investor is Johnson & Johnson Development Corporation (JJDC)?

Johnson & Johnson Development Corporation (JJDC) is a VC firm based in United States.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=johnson-and-johnson-development-corporation) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=johnson-and-johnson-development-corporation)